Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 25.65% is in line with its 5-year average of 27.37%, around the middle of its 5-year range (10.97%–32.26%).
As of the fiscal period ended Tuesday, March 31, 2026. 7.74% below its 12-month average of 27.80%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
25.65%
EBITDA MARGIN AVG TTM
27.80%
EBITDA MARGIN AVG 3Y
29.09%
EBITDA MARGIN AVG 5Y
28.78%
EBITDA MARGIN AVG 10Y
27.78%
EBITDA MARGIN AVG 15Y
28.58%
EBITDA MARGIN AVG 20Y
29.86%
CURRENT VS TTM AVG
-7.74%
CURRENT VS 3Y AVG
-11.82%
CURRENT VS 5Y AVG
-10.86%
CURRENT VS 10Y AVG
-7.67%
CURRENT VS 15Y AVG
-10.25%
CURRENT VS 20Y AVG
-14.08%
Zimmer Biomet Holdings, Inc.
Market Cap
$18.44B
EBITDA Margin
25.65%
TTM Avg
27.80%
3Y Avg
29.09%
5Y Avg
28.78%
Market Cap
$15.90B
EBITDA Margin
22.25%
TTM Avg
22.41%
3Y Avg
21.18%
5Y Avg
20.68%
Market Cap
$15.11B
EBITDA Margin
32.07%
TTM Avg
25.68%
3Y Avg
26.69%
5Y Avg
27.49%
Market Cap
$22.08B
EBITDA Margin
50.36%
TTM Avg
50.37%
3Y Avg
51.80%
5Y Avg
47.75%
Market Cap
$14.53B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$14.29B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.44B | 25.65% | 27.80% | 29.09% | 28.78% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 24.73% | 27.15% | 30.37% | 35.33% |
| Viatris Inc. (VTRS)vs › | $20.54B | 0.95% | 10.32% | 17.98% | 18.96% |
| Medpace Holdings, Inc. (MEDP)vs › | $15.90B | 22.25% | 22.41% | 21.18% | 20.68% |
| Solventum Corporation (SOLV)vs › | $15.11B | 32.07% | 25.68% | 26.69% | 27.49% |
| United Therapeutics Corporation (UTHR)vs › | $22.08B | 50.36% | 50.37% | 51.80% | 47.75% |
| DaVita Inc. (DVA)vs › | $14.59B | 19.98% | 20.97% | 19.78% | 20.10% |
| The Cooper Companies, Inc. (COO)vs › | $14.53B | 27.02% | 27.38% | 26.41% | 26.36% |
| Baxter International Inc. (BAX)vs › | $14.29B | 5.99% | 7.75% | 3.55% | 8.89% |
| STERIS plc (STE)vs › | $22.67B | 26.76% | 25.68% | 26.35% | 25.75% |
Gross Margin
61.6%
EBITDA Margin
25.7%
Operating Margin
15.6%
Net Margin
9.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 25.65% |
| 2025-12-31 | 25.48% |
| 2025-09-30 | 31.72% |
| 2025-06-30 | 27.53% |
| 2025-03-31 | 28.64% |
| 2024-12-31 | 32.26% |
| 2024-09-30 | 29.08% |
| 2024-06-30 | 30.61% |
| 2024-03-31 | 26.70% |
| 2023-12-31 | 30.69% |
| 2023-09-30 | 28.96% |
| 2023-06-30 | 30.33% |
| 2023-03-31 | 30.54% |
| 2022-12-31 | 10.97% |
| 2022-09-30 | 28.55% |
| 2022-06-30 | 28.82% |
| 2022-03-31 | 25.99% |
| 2021-12-31 | 16.99% |
| 2021-09-30 | 28.24% |
| 2021-06-30 | 26.12% |
| 2021-03-31 | 30.87% |
| 2020-12-31 | 24.27% |
| 2020-09-30 | 28.91% |
| 2020-06-30 | 6.85% |
| 2020-03-31 | -11.38% |
| 2019-12-31 | 27.79% |
| 2019-09-30 | 26.28% |
| 2019-06-30 | 23.02% |
| 2019-03-31 | 30.27% |
| 2018-12-31 | -25.87% |
| 2018-09-30 | 26.35% |
| 2018-06-30 | 27.77% |
| 2018-03-31 | 28.18% |
| 2017-12-31 | 10.92% |
| 2017-09-30 | 26.35% |
| 2017-06-30 | 27.91% |
| 2017-03-31 | 31.22% |
| 2016-12-31 | 21.62% |
| 2016-09-30 | 26.39% |
| 2016-06-30 | 23.47% |
| 2016-03-31 | 25.86% |
| 2015-12-31 | 25.74% |
| 2015-09-30 | 20.17% |
| 2015-06-30 | -2.78% |
| 2015-03-31 | 31.64% |
| 2014-12-31 | 26.04% |
| 2014-09-30 | 31.29% |
| 2014-06-30 | 29.77% |
| 2014-03-31 | 34.53% |
| 2013-12-31 | 32.68% |
| 2013-09-30 | 28.26% |
| 2013-06-30 | 25.81% |
| 2013-03-31 | 33.66% |
| 2012-12-31 | 24.63% |
| 2012-09-30 | 32.38% |
| 2012-06-30 | 35.14% |
| 2012-03-31 | 34.40% |
| 2011-12-31 | 25.31% |
| 2011-09-30 | 34.66% |
| 2011-06-30 | 30.57% |
| 2011-03-31 | 34.36% |
| 2010-12-31 | 18.82% |
| 2010-09-30 | 36.82% |
| 2010-06-30 | 29.21% |
| 2010-03-31 | 35.66% |
| 2009-12-31 | 29.47% |
| 2009-09-30 | 29.95% |
| 2009-06-30 | 37.09% |
| 2009-03-31 | 36.21% |
| 2008-12-31 | 30.95% |
| 2008-09-30 | 29.10% |
| 2008-06-30 | 34.81% |
| 2008-03-31 | 37.14% |
| 2007-12-31 | 38.59% |
| 2007-09-30 | 20.39% |
| 2007-06-30 | 39.00% |
| 2007-03-31 | 40.05% |
| 2006-12-31 | 41.87% |
| 2006-09-30 | 37.30% |
| 2006-06-30 | 37.34% |
| 2006-03-31 | 39.13% |
| 2005-12-31 | 38.98% |
| 2005-09-30 | 37.53% |
| 2005-06-30 | 37.92% |
| 2005-03-31 | 36.54% |
| 2004-12-31 | 35.99% |
| 2004-09-30 | 34.18% |
| 2004-06-30 | 30.02% |
| 2004-03-31 | 26.34% |
| 2003-12-31 | 15.12% |
| 2003-09-30 | 37.62% |
| 2003-06-30 | 38.07% |
| 2003-03-31 | 36.30% |
| 2002-12-31 | 31.79% |
| 2002-09-30 | 30.96% |
| 2002-06-30 | 31.89% |
